减少危害及其在欧洲的监测,从EMCDDA到EUDA
1EUDA, Praça Europa 1, Cais do Sodré, 1249-289, Lisbon, Portugal. Alexis.Goosdeel@euda.europa.eu.
Harm reduction journal
|December 20, 2024
概括
减少伤害,源于艾滋病毒/艾滋病危机,已经发展成为一个全球战略. 它优先考虑以人为中心的护理,并在欧洲成功地减少了与毒品有关的伤害和感染.
科学领域:
- 公共卫生 公共卫生
- 社会学 社会学 社会学
- 政策研究 政策研究
背景情况:
- 危害减少在20世纪80年代概念化,从艾滋病毒/艾滋病危机中出现,以解决与毒品有关的感染和医疗保健负担.
- 早期的举措,如阿片类药物替代治疗 (OST) 和针交换计划面临阻力,但确立了以人为中心的护理标准.
研究的目的:
- 探索减少伤害的演变,从一个艾滋病毒/艾滋病预防战略到一个广泛的欧洲框架.
- 分析欧盟政策和倡议对减少与毒品有关的伤害和传染病的影响.
主要方法:
- 危害减轻的发展和扩张在欧洲的审查.
- 分析欧盟的政策,倡议 (OST,针头交换,毒品消费室,药物检查) 以及欧洲疾病预防控制与预防中心 (现欧盟药品和药物管理局) 的作用.
- 考虑C型肝炎治疗和民间社会合作方面的进展.
主要成果:
- 降低危害原则在欧洲得到了认可,得到了欧盟政策和联合国的支持.
- 像OST和针交换计划这样的倡议已经成功地减少了与毒品有关的死亡和传染病.
- 型肝炎治疗的进步提高了健康结果和患者伙伴关系.
结论:
- 不断变化的毒品环境需要重新定义降低伤害的方法,以解决多种药物使用和暴力问题.
- 欧盟农业署的新任务重点是预测和应对新出现的与毒品有关的挑战.
- 与民间社会合作对于包容性,适应性欧盟毒品政策至关重要.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
141
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
141
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Drug Therapy
38
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
38


